Clinical trials of pluripotent cells are already happening, though they hark back to the days when only cells derived from embryos were available. An American firm called Advanced Cell Technology (ACT) is using them to treat macular degeneration, a cause of blindness. Last year it reported promising results in two patients and Gary Rabin, the firm’s boss, says tests continue.
Even if this specific approach works, though, it is likely to be overtaken by iPS technology. The Japanese, not surprisingly, are in the lead. Soon, the country’s health ministry is expected to approve the first clinical trial of iPS cells, also for macular degeneration. But ACT is not far behind. It hopes to begin a trial of platelets (blood-cell fragments involved in clotting) made from iPS cells. And other firms want to treat everything from Parkinson’s disease to glaucoma to multiple sclerosis.
So the Japanese are ahead of Americans (i.e. ACTC)???? So I'm confused. I thought that ACTC was the first performing Clinical trials treating MD macular degeneration and Dry AMD.
Anyway, there goes ACTC's intellectual property portfolios which includes pluripotent stem cell platforms comprising embryonic stem cell and induced pluripotent stem cell (iPSC) platforms; and all their other cell therapy research programs, such as opthamology, autoimmune/inflammation, and platelet programs. This is why, it's time to "Stop" trying for the golden goose prize and get what they can "NOW". Others will be stealing the intellectual properties and ACTC can't finance any legal battles, tryping to prove the intellectual properties were discovered by them. ACTC is smart in science but dumb in their business model. (i.e. hold for the biggest bidder) Absolutely DUMB.
Marju, are you selling subscriptions for the Economist mag? I believe that it's point of view is slanted toward the right, and anti-ESC, thus making it good only for lining a bird cage floor.
Keep, I would say that you are unbelievable, but that wouldn't do justice to the daily ignorance you bring to this MB. Good grief man, can you just take a moment and think before posting? I believe that deep down you are a good person, you just need to stop and think before you alienate every single person who visits the web. Just something to think about.....
Unfortunately short and scant details. If, however, it get's more people to invest and learn about the firm, then it will be a positive for the shareholders.
Need completion of the Phase I trial and R/S......